Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company's lead autoimmune program DT-001, targeting

Related Keywords

Munich ,Bayern ,Germany ,Dublin ,Ireland ,Paris ,France General ,France ,New York ,United States ,Netherlands ,Leuven ,Gelderland ,Milan ,Lombardia ,Italy ,Belgium ,Singapore ,Bernard Coulie ,Lucy Featherstone ,Aneta Sottil ,Juliette Audet ,Luc Van Rompaey ,Andera Croissance ,Wouter Verhoeven ,Bandera Co ,Novartis ,Ghent University ,Consilium Strategic Communications ,Wurzburg University ,Andera Life Sciences ,Fountain Healthcare Partners ,Independent Chairman ,Andera Partners ,V Bio Ventures ,Pliant Therapeutics ,Van Rompaey ,Healthcare Partners ,Newamsterdam Pharma ,United Nations Principles ,Andera Midcap ,Andera Expansion ,Andera Co Invest ,Andera Acto ,Andera Infra ,Gefallene Big Techs ,Dualyx ,Raises ,Billion ,Progress ,Greg ,Therapies ,Autoimmune ,Diseases ,Clinic ,